Vincerx Pharma Inc share price logo

Vincerx Pharma Inc Share Price

NASDAQ: VINC

$0.04

-0.03

(-46.34%)

as on

Bell Icon

The stock has been delisted from the stock exchange on 22 Apr 2025

Vincerx Pharma Inc Stock Performance

as on September 25, 2025 at 7:32 pm IST

  • Day's Low

    Day's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.08
    $10.37
    downward going graph

    -101.25%

    Downside

    25835.00%

    Upside

    downward going graph

Vincerx Pharma Inc share price movements today

Previous Close
$0.07
Open
-
Volume
-
52 Week Low - High
$0.08 - $10.37

Vincerx Pharma Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Vincerx Pharma Inc Stock Fundamentals & Key Indicators

Check Vincerx Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Vincerx Pharma Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Vincerx Pharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$-NANA0.00%

Analyst Recommendation on Vincerx Pharma Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Vincerx Pharma Inc. Average target price of $200

Vincerx Pharma Inc Share Price Target

Get share price movements and forecasts by analysts on Vincerx Pharma Inc.

What analysts predicted

99.98%UPSIDE

Target Price

$200

Current Price

$0.04

Analyzed by

9 Analysts

Target

$200.00

Vincerx Pharma Inc target price $200, a slight upside of 99.98% compared to current price of $0.04. According to 9 analysts rating.

Vincerx Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Total Revenue
-
-
-
-
-
1
-
-
-
-
Gross Profit
0
0
0
0
0
1
0
0
-
-
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-16
-5
-13
-11
-9
-4
-12
-1
-7
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-376.71%
0.00%
0.00%
0.00%
0.00%

Vincerx Pharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
Gross Profit
0
0
0
0
-
Operating Income
-
-
-
-
-
EBITDA
-
-
-
-
-
Interest Expense
-
-
-
-
-
Depreciation
-
-
-
-
-
Income Before Tax
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
Net Income
-10
-15
-57
-40
-30
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Global Institutional Holdings in Vincerx Pharma Inc

Funds
Holdings
SAGE RHINO CAPITAL LLC
1.63%
Rock Springs Capital Management LP
0.85%
Armistice Capital, LLC
0.54%
Geode Capital Management, LLC
0.23%
Rubric Capital Management LP
0.11%

About Vincerx Pharma Inc

Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing differentiated and novel therapies to address the unmet medical needs of patients with cancer. It has a next generation bioconjugation platform, called VersAptx. Its product candidates include VIP943 (CD123-KSPi), VIP924 (CXCR5-KSPi), VIP236, and Enitociclib (positive transcription elongation factor beta (P-TEFb)/CDK9 inhibitor). Its VIP943 is developed using its VersAptx platform and combines an anti-CD123 antibody, a novel legumain-cleavable linker and a kinesin spindle protein inhibitor payload enhanced with CellTrapper technology. Enitociclib is a selective CDK9 inhibitor. Enitociclib effectively blocks P-TEFb-mediated activation of RNA polymerase II, preventing transcription of MCL1 and MYC, proteins associated with poor prognosis in various types of cancer.
OrganisationVincerx Pharma Inc
E-voting on sharesClick here to vote

FAQs

What is Vincerx Pharma Inc share price today?

Vincerx Pharma Inc share price today is $0.04 as on at the close of the market.

What is the 52 week high and 52 week low for Vincerx Pharma Inc share?

Vincerx Pharma Inc share touched a 52 week high of $10.37 on and a 52 week low of $0.08 on . Vincerx Pharma Inc stock price today i.e. is closed at $0.04,which is 99.61% down from its 52 week high and -50.31% up from its 52 week low.

How to invest in Vincerx Pharma Inc Stock (VINC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vincerx Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vincerx Pharma Inc Shares that will get you 37.5000 shares as per Vincerx Pharma Inc share price of $0.04 per share as on September 25, 2025 at 7:32 pm IST.

What is the minimum amount required to buy Vincerx Pharma Inc Stock (VINC) from India?

Indian investors can start investing in Vincerx Pharma Inc (VINC) shares with as little as ₹87.965 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.65 in Vincerx Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Vincerx Pharma Inc share’s latest price of $0.04 as on September 25, 2025 at 7:32 pm IST, you will get 250.0000 shares of Vincerx Pharma Inc. Learn more about fractional shares .